Dual-zielgerichtete Therapie des HER2-positiven Mammakarzinoms
Crossref DOI link: https://doi.org/10.1007/s00129-015-3750-8
Published Online: 2015-07-30
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jäger, Bernadette
Janni, W.
Fink, V.
Huober, J.
Text and Data Mining valid from 2015-07-30